Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
New test may predict breast cancer metastasis
April 28th, 2009
Researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center have identified a new marker for breast cancer metastasis called TMEM, for Tumor Microenvironment of Metastasis. As reported in the March 24 online edition of the journal Clinical Cancer Research, density of TMEM was associated with the development of distant organ metastasis via the bloodstream -- the most common cause of death from breast cancer. The National Cancer Institute (NCI)–funded translational study could lead to the first test to predict the likelihood of breast cancer metastasis via the bloodstream -- a development that could change the way breast cancer is treated. ...
Source: Cancer Weekly (2009-04-28)
|
